Hip
Senior Member
- Messages
- 18,110
As yet, we don't yet have compelling clinical trial evidence that it has potent treatment effects in paitients with chronic enterovirus infections/encephalitis/acute flacid paralysis. (I must admit I'm curious about the latter)
There is this paper, which found in a young boy with chronic enterovirus encephalitis, fluoxetine was able to improve his condition. But apart from that, I don't know of any other cases of fluoxetine being used as an antiviral for enterovirus.
I've recently been reading and learning a bit about pharmacokinetics (the study of how drugs distribute in the body tissues), and by my calculation, the concentration of free (unbound) fluoxetine in the brain tissues is over 500 times the free fluoxetine in the blood plasma (it is usually only the free drug, not the blood plasma protein-bound drug, that has active effects in the body; in the blood, fluoxetine is 95% protein-bound, which is part of the reason for its weak effects in the blood).
My calculation also showed that even low doses (eg 10 mg daily) of fluoxetine will have a potent antiviral effect in the brain.
So fluoxetine is hugely more potent as an antiviral in the brain, compared to the blood. Thus the fact that fluoxetine shows little benefit for ME/CFS suggests that perhaps enterovirus infections in the brain are not a major cause or factor in ME/CFS (but enterovirus in other tissues such as the muscles or gut might be, and fluoxetine has little antiviral effect in these tissues).
Or it might be that you don't get improvements in ME/CFS until you clear out the enterovirus infection in all of your tissues.